Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Here we are again

<< Previous

Bullboard Posts

Next >>

Comment by McBullishon Nov 06, 2024 2:42pm

193 Views

Post# 36299392

RE:RE:Here we are again

Thanks for clarifying.

I ask these questions because I am unfamiliar with the process and associated timelines.

Theres a lot of speculative BS, both positive and negative, posted on this board and I am trying to get a handle on the likelihood that BTD would be assigned.

If our Pre-BTD was accepted or had minor revisions requested, what is the percentage chance of BTD approval?

<< Previous

Bullboard Posts

Next >>

Debt-free cannabis company set for next stage of growth